SI1309607T1 - Method for producing lhrh antagonists - Google Patents

Method for producing lhrh antagonists

Info

Publication number
SI1309607T1
SI1309607T1 SI200130237T SI200130237T SI1309607T1 SI 1309607 T1 SI1309607 T1 SI 1309607T1 SI 200130237 T SI200130237 T SI 200130237T SI 200130237 T SI200130237 T SI 200130237T SI 1309607 T1 SI1309607 T1 SI 1309607T1
Authority
SI
Slovenia
Prior art keywords
producing
lhrh antagonists
lhrh
antagonists
producing lhrh
Prior art date
Application number
SI200130237T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Damm
Waldemar Salonek
J�Rgen Engel
Horst Bauer
Gabriele Stach
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1309607(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of SI1309607T1 publication Critical patent/SI1309607T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SI200130237T 2000-08-17 2001-08-09 Method for producing lhrh antagonists SI1309607T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (de) 2000-08-17 2000-08-17 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
EP01978273A EP1309607B1 (de) 2000-08-17 2001-08-09 Verfahren zur herstellung von lhrh-antagonisten
PCT/EP2001/009219 WO2002014347A2 (de) 2000-08-17 2001-08-09 Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (1)

Publication Number Publication Date
SI1309607T1 true SI1309607T1 (en) 2005-02-28

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130237T SI1309607T1 (en) 2000-08-17 2001-08-09 Method for producing lhrh antagonists

Country Status (30)

Country Link
US (1) US6780972B2 (es)
EP (1) EP1309607B1 (es)
JP (1) JP2004506647A (es)
CN (1) CN1187369C (es)
AR (1) AR030371A1 (es)
AT (1) ATE280779T1 (es)
AU (2) AU1043902A (es)
BG (1) BG107612A (es)
BR (1) BR0113296A (es)
CA (1) CA2355573A1 (es)
CZ (1) CZ2003688A3 (es)
DE (2) DE10040700A1 (es)
DK (1) DK1309607T3 (es)
EE (1) EE200300065A (es)
ES (1) ES2230371T3 (es)
HK (1) HK1058366A1 (es)
HU (1) HUP0300738A3 (es)
IL (1) IL154150A0 (es)
MX (1) MXPA03001448A (es)
NO (1) NO20030618L (es)
NZ (1) NZ524023A (es)
PL (1) PL204496B1 (es)
PT (1) PT1309607E (es)
RU (1) RU2266296C2 (es)
SI (1) SI1309607T1 (es)
SK (1) SK3032003A3 (es)
TW (1) TWI236910B (es)
UA (1) UA74005C2 (es)
WO (1) WO2002014347A2 (es)
ZA (1) ZA200300777B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
RU2525661C2 (ru) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин
CN107056894B (zh) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 一种片段法固相合成醋酸加尼瑞克的方法
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800A (zh) * 2020-09-22 2022-03-29 深圳市星银医药有限公司 一种双羟萘酸多肽药物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
EP0041286B1 (en) * 1980-06-02 1984-08-15 Andrew Victor Schally Lh-rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
HUP0100221A3 (en) * 1998-01-16 2002-11-28 Takeda Pharmaceutical Sustained release compositions, process for producing the same and utilization thereof

Also Published As

Publication number Publication date
AU1043902A (en) 2002-02-25
EP1309607B1 (de) 2004-10-27
HUP0300738A2 (hu) 2003-09-29
WO2002014347A2 (de) 2002-02-21
TWI236910B (en) 2005-08-01
PL359495A1 (en) 2004-08-23
DE50104316D1 (de) 2004-12-02
IL154150A0 (en) 2003-07-31
PT1309607E (pt) 2005-02-28
CN1447817A (zh) 2003-10-08
NO20030618D0 (no) 2003-02-07
ES2230371T3 (es) 2005-05-01
HUP0300738A3 (en) 2004-08-30
ZA200300777B (en) 2003-09-18
BG107612A (bg) 2003-12-31
AR030371A1 (es) 2003-08-20
PL204496B1 (pl) 2010-01-29
ATE280779T1 (de) 2004-11-15
BR0113296A (pt) 2003-07-15
NO20030618L (no) 2003-02-07
WO2002014347A3 (de) 2002-08-08
SK3032003A3 (en) 2004-05-04
UA74005C2 (en) 2005-10-17
CZ2003688A3 (cs) 2004-03-17
NZ524023A (en) 2004-11-26
EE200300065A (et) 2004-12-15
JP2004506647A (ja) 2004-03-04
CN1187369C (zh) 2005-02-02
MXPA03001448A (es) 2004-12-13
DK1309607T3 (da) 2005-01-17
US20020198146A1 (en) 2002-12-26
HK1058366A1 (en) 2004-05-14
US6780972B2 (en) 2004-08-24
RU2003107560A (ru) 2005-01-27
EP1309607A2 (de) 2003-05-14
AU2002210439B2 (en) 2005-10-20
RU2266296C2 (ru) 2005-12-20
DE10040700A1 (de) 2002-02-28
CA2355573A1 (en) 2003-02-22

Similar Documents

Publication Publication Date Title
HUP0303365A3 (en) Method for making polyamides
GB0016459D0 (en) Method
EG23017A (en) Method for producing brushware
AU7090201A (en) Method
AU1708902A (en) Method for producing sulfonamide-substituted imidazotriazinones
GB0009353D0 (en) Method
PL361146A1 (en) Method for producing isocyanato-organosilanes
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
EP1324238A4 (en) DISTRIBUTION METHOD
SI1309607T1 (en) Method for producing lhrh antagonists
GB0005867D0 (en) Method
GB0007873D0 (en) Method
AU7265900A (en) Method for producing otoplastics
GB0018039D0 (en) Method
GB0013260D0 (en) Method
HUP0204192A3 (en) Method for producing n-alkoxy-n-alkylamides
AU1079002A (en) Method for making micromolds
GB0017752D0 (en) Prototyping method
GB0003440D0 (en) Method
GB0020357D0 (en) Method
GB0003837D0 (en) Method
GB0000663D0 (en) Method
GB0006034D0 (en) Method
GB0006590D0 (en) Method
GB0006853D0 (en) Method